The report on the global oral proteins and peptides market provides qualitative and quantitative analysis for the period from 2016 to 2024.
The report predicts the global oral proteins and peptides market to grow with a CAGR of 12.6% over the forecast period from 2018-2024. The study on oral proteins and peptides market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.
The report on oral proteins and peptides market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global oral proteins and peptides market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global oral proteins and peptides market over the period of 2016 to 2024. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings 1) Drivers • Improvement in healthcare infrastructure • Increase in prevalence of chronic diseases • Increase in geriatric population 2) Restraints • High costs connected with drug development 3) Opportunities • Growth in purchasing power in emerging countries
A) Primary Research Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include 1. Key Opinion Leaders associated with Infinium Global Research 2. Internal and External subject matter experts 3. Professionals and participants from the industry
Our primary research respondents typically include 1. Executives working with leading companies in the market under review 2. Product/brand/marketing managers 3. CXO level executives 4. Regional/zonal/ country managers 5. Vice President level executives.
B) Secondary Research Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include 1. Company reports and publications 2. Government/institutional publications 3. Trade and associations journals 4. Databases such as WTO, OECD, World Bank, and among others. 5. Websites and publications by research agencies
Segment Covered The global oral proteins and peptides market is segmented on the basis of drug type, and application.
The Global Oral Proteins and Peptides Market by Drug Type • Octreotide • Linaclotide • Insulin • Plecanatide • Calcitonin
The Global Oral Proteins and Peptides Market by Application • Hormonal Disorders • Gastric & Digestive Disorders • Diabetes • Bone Diseases
Company Profiles • Chiasma Inc. • Allergan Plc. • Biocon Limited • Generex Biotechnology Corp. • Oramed Pharmaceuticals Inc. • Synergy Pharmaceuticals Inc. • AstraZeneca PLC • Novo Nordisk A/S • Proxima Concepts Limited • Tarsa Therapeutics Inc.
What does this report deliver? 1. Comprehensive analysis of the global as well as regional markets of the oral proteins and peptides market. 2. Complete coverage of all the segments in the oral proteins and peptides market to analyze the trends, developments in the global market and forecast of market size up to 2024. 3. Comprehensive analysis of the companies operating in the global oral proteins and peptides market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company. 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Our reports have been used by over 10K customers, including:
135 pages •
By Infiniti Research Limited
• Oct 2019
Human Insulin Drugs Market in Brazil: About this market This human insulin drugs market in brazil market analysis considers sales from basal insulin analog and NPH products. Our study also finds the sales of the human insulin drugs market in brazil in retail and hospital distribution channels. In 2018, the basal insulin...
247 pages •
By Asia Market Information & Development Company
• Oct 2019
China’s demand for Incretion Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
Report Scope: This new report on pediatric medicine will provide a brief overview on the current status of the industry and recent developments.It presents the changing environment in terms of new legislation and implementation of global pediatric plans. The report analyzes market trends and identifies key therapeutic...
164 pages •
By Global Industry Analysts
• Oct 2019
Wearable Injectors market worldwide is projected to grow by US$4.5 Billion, driven by a compounded growth of 10.7%. On-Body injectors, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast...
345 pages •
By Global Industry Analysts
• Oct 2019
Allergy Diagnostics market worldwide is projected to grow by US$3.7 Billion, driven by a compounded growth of 10.2%. Assay Kits, one of the segments analyzed and sized in this study, displays the potential to grow at over 10.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the...
Cat Allergy - Pipeline Review, H2 2019 Summary The latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Pipeline Review, H2 2019, provides an overview of the Cat Allergy (Immunology) pipeline landscape. Cat allergy is an allergic reaction to one or more allergens produced...